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Activation of endothelium is a critical event during 
the initiation of inflammatory processes and is asso-
ciated with the induction of cell adhesion molecules 
and cytokines. The latter include chemotactically 
active cytokines (chemokines) that promote leuko-
cyte diapedesis from the circulation to sites of evolv-
ing inflammation. In this study we evaluated the 
chemokine repertoire of human endothelial cells de-
rived from the skin (HDMECs) and regulation of 
these chemokines by cytokines. HDMECs and an 
inlmortalized human dermal microvascular endothe-
lial cell line, HMEC-I, were investigated for the 
expression of C-X-C and C-C chemokines at mRNA 
and protein levels. Upon stimulation with interleu-
kin-IJ3 (IL-IJ3) and tumor necrosis factor-a (TNF-a), 
both HDMECs and HMEC-I expressed high levels of 
JL-.S, GRO, and monocyte chemoattractant protein-I 
(MCP-I). RANTES was only weakly induced; how-
E nd. othelial ~ells, strategically located between intravas-cular and tissue compartments, se rve as key rcgulators of leukocyte trafficking during the initial phase of inflammation. Their activation is associated with a multi- step cascade of events that results in the local 
recruitment of leukocytes . Selectins and members of the immuno-
globulin superfamily are up-regulated upo n inflammatory stimula-
tion and m ediate rolling, adhesion, and transmigration of leuko-
cytes from the blood stream to the und erlying tissuc (OsbolTl, 1990; 
Springer, 1994) . Moreover, chcmotactically active cytokines (i.c., 
chemokines) are increasingl y being appreciated as ca pable of 
regulating signals that promote recruitment of lcukocyte subsets. 
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human umbilical vein endothelial ce ll ; MCP-I, monocyte chemo;Jttractant 
protein-1; M.lP-l Ct and {3, macrophage inflammatory protein-'1 c< and {3: 
RANTES, regulated on activation normal T-cell expressed and secreted. 
ever, concomitant treatment with TNF-a and inter-
feron-l' (IFN-l') led to up regulation of RANTES, 
indicating a synergy between these two cytokines. 
The C-X-C chemokine IFN-inducible protein-IO was 
upregulated by IFN-l' but not by other cytokines 
studied. Macrophage inflammatory protein-I a and 13, 
1-309, and ENA-7S could not be induced. The chemo-
kine repertoires ofHDMECs and HMEC-I were com-
pared to those of human umbilical vein endothelium 
and found to be rather similar with the important 
exception that IFN-l' and IL-4 up-regulated MCP-I 
only in macrovascular endothelium. Our data indi-
cate that HDMECs contribute to the dermal cytokine 
network by selective production of MCP-I, IL-S, 
GRO, RANTES, and IP-IO, which may critically influ-
ence the site-specific recruitment of leukocyte subsets. 
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The combinatorial use of difFercnt chcmotactic signa ls may explain 
thc diverse patte rn s of lcukocyte infiltratcs observed in inflamma-
tory reactions. C hemokines may be prcscnted on the luminal 
surface of endothe lia l cells, where they a.re immobilized to surfacc 
proteoglycans, to guide leukocyte migration across the vascular 
wall. Such mcchanisms have bccn demonstrated for m acrophage 
inflamma tory protcin-l,B (M IP-1 ,B)-induced binding of T cells to 
vascular cell adhcsion molecule-I (Tanaka et nl, 1993) or surf;lce-
bound interle ukin (IL)-8, which may serve as a ligand for neutro-
phil s (Kot et nl, 1996). Furthcrmorc, cndothelial cell s thcmsclvcs 
appear to produce difFcrent chcmokincs of both thc C -X-C and 
C - C subfamilies. T hcy Illay contributc . as sh own for m on ocytc 
chcmoa ttractant protein-l (MCP-1), to the establishment of a 
gradient of soluble ch emoattrac tants (Randolph and Furic, 1995), 
t ilU S faci li tating subset- spccific rccruitlllcnt of lcukocytcs. C-C 
chemokin es such as MCP-1 , MlP-I O' . MIP-1,B. 1-309. and 
I~NTES (regulatcd on activation normal T-cell exprcssed and 
sccreted) cxhibi t chcm oattractant activity for monocytes, lympho-
cytes (MCP-l, MIP-IO', MIP-1,B, and RANTES), eosinophils 
(flANTES), and basophil s (MCP-I) . whcrcas C -X-C chemokines 
such as IL-8, GRO (growth-regulated), and ENA-78 prefcrcntially 
attract n cutrophils (Baggiolini ct nl, 1994; Sprin ger, 1994). 
Most of the data con ccrn ing endothdial ccll functions h ave been 
obta.ined by stud ying macrovascu lar endothelium , e.g .. human 
umbilical vcin endothelial cc lls (HUVECs). T he emigration of 
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leukocytes from blood to the tissues, however, takes place at the 
level of the postcapillary venules. Increasing evide n ce exists for 
structural and functional differences between endothelial cells 
obtained from different sites (Mantovani et aI, 1992; Swe rlick el aI, 
1992a, 1992b; Petzelbauer et aI, 1993; Swerlick and Lawley, 1993; 
Grager et ai, 1996). To unde rstand the role of ch emokin es in 
inflammatory skin diseases, it is, therefore, important to analyze 
their expression and modulation in region-specific cell s, i. e., d erma l 
microvascular endothelium. W e therefore initiated this study to 
investigate the chemokine repertoire of hum an dermal tnicrovas-
cular e ndothe li al cells (HDMECs) and its regulation by proinflam-
matory cytokines. In addition , exp erimental data were compared 
with those obtained from an immortalized human d ermal micro-
vascul ar endothelial cell line, HMEC-l (Ades el aI, 1992), and from 
HUVECs. W e demonstrate that dermal microvascular endothelium 
has a distinc t repertoire of ch emokines that may contribute to 
subset-specific recruitment of leukocytes to the skin. 
MATERJALS AND METHODS 
Cells and Cell Culture HUVECs and HDMECs were isolated from 
umbilical cords (Goebeler ef nl, 1995) or foreskins (Ruszczak el nl, 1990) as 
described . Alternatively, HUVECs and HDMECs were obtaiJlcd from 
C loncti cs (Walkersvil.le, MD; via Cell Systems, Remagen, FRG). 
HMEC-l , an immortalized human microvascular endothelial ce lllinc (Adcs 
el nl, 1992), w as kindly provided b y Dr. E.W. Ades (Centers for Diseasc 
Comol, Atlanta, GA) and Dr. T .). Lawley (Emory University, Atlanta, GA). 
Cells were cu ltured with EBM medium supplemented with 2'Vt, (HUVECs, 
HMEC-1) or 5% fetal bovine serum (HDMECs), 1.0 ILg hydrocortisone per 
ml , 10 ng human epidermal growth factor per ml , 12 ILg bovine brain 
extract per ml, 50 ILg gentamicin per ml , and 50 ng amphotericin B per ml 
(i .e .. EG M mcdium , C lonetics). HDMECs and HUVECs wcre used bc-
tween passages 3 and 6. 
Reagents lnterferon-1' (IFN-I'; spccific activity, 3 X 1 O~ units per mg) 
and 11-4 (specific activity. 107 units per mg) were purchascd from Pepro-
T ech (London , England) and R&D Systems (Wiesbaden , Gcrmany), IL-I {3 
(spec ific activity, > 5 X 107 units per mg) fi'om Boehringcr Mannhcim 
(Mannheim, Gcnnany), and tumor necorsis factor-a (TNF-a; spec ific 
activity 10" units per mg) from PBH (Hannover, Ge rmany). MCl'-1 cDNA 
was cloned as reported (Yoshimura et nl,1989). Other cDNA probes 
employcd for ill silll hybridization were provided by Genetics Institute 
(Cambridge, MA; MIP-l a) , M. Krangcl (Duke U ni versity Medical Ccntcr, 
Durham, NC; 1-309) , T . Schall (DNAX, Palo Alto, CA; RANTES and 
MIP-I (3) , V. Mielke (University of Ulm , Gennany; IL-8) , C. W eiSSmanJl 
(University of Zurich, Switzcrland; I.L-8) , R. Kulke [Univcrsity of K id, 
Germany; IFN-I'-induciblc protein-l 0 (IP-l 0)], A. fuusowi cz (Dana-Farber 
Cancer lnstitlltc, Boston, MA; GRO), and A. Wa.lz (U,uversity of Bern , 
Switzerland; ENA-78). SubclOlun g of specific DNA fragments in plasmids 
containing SP6/T7 (Promega, Madison, WI) o r T3/T7 ilutiation sites 
(B1ueScript SK/ KS; Stratagene, La J olla, CA) was performcd by standard 
protocols (Sambrook el nl, 1989). 
[II Sit" Hybridization Preparation of 35S_labeled RNA probcs was 
perfon1led as described (Ritter cl nl, 1996). Aftcr lincarization of plasmid 
DNA with appropriate restriction enzymes , ill vil,.o transcrip tion using SP6, 
T3 , or T7 RNA polymerases with adenosine 5' -triphosphate, cytidine 
5' -triphosphate, guanosine 5' -triphosphate (Boehringer Mannheim), and 
35S-labeled uridine 5' -triphosphate (Amersham, Braunschweig, Germany) 
as substrates were performed to obta in sense and anti-sense pro bes. After ;1/ 
"ilm transcription, the original cDNA was digestcd with DNase and protein 
components were eliminated by severa l phenol extraction steps. To obtain 
RNA probes 50-150 bp long, alkaline hydrolysis was performed for 30 to 
55 min at 60· C in a carbonate buffe r (pH 10.2) accord ing to the formula: 
incubation time for alkaline hydrolysis (minutes) = (Ln - L,)lO.ll X L" X 
Lp (L() = initial length in kilobases. and Lr = final size in kilobases). Size 
reduction f:,cilitates penetration of the probes into the cell s and, thus, 
increases sensitivity and avoids extcnsive protease treatments that would 
impair cell morphology. After several ethanol precip itations, radioactive 
riboprobes were adjusted to a specific activity of2 X 10(0 cpm per ILl in 0.01 
M Tris(hydroxymetbyl)aminomethane hydrochloride, pH 7.5 , supple-
mented with 1 mM ethylencdiamulc tetra acetic acid. 
Hybridization Procedure Til s;11I hybridi zation was done as described 
(Ritter el nl, 1996) . Endothelial ce lls were sedimentatcd on RNase-free 
lysine-coated slides, air-dried, fixed with 4% para formaldehyde Ul phos-
phate-buffered saline (20 min at room temperarure), and deh ydrated. After 
preparation of sense and anti-sense probes, paraformaldehyde-fixed ce lls 
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were treated with proteinase K (1 ILg per ml , Boehringer MalUlheim, 
Mannheim, Germany) for 30 min at 37·C to f:1c ilitate the intracc llular access 
of the riboprobes , refixed in paraformaldehyde (4%, 20 min at room 
temperature) , and ace tylated with acetic anhydride in 0.1 M triethanolamine 
(pH 8.0, 10 min at room temperature) . Afterward, slides w ere dehydrated 
in a graded alcoho l series and air-dricd. T hereafter, the cells were overl aid 
with hyb ridization so lu tion containing 50'Y. formamide, 300 mM NaCI, 20 
mM Tris(hydroxymethyl)aminomethanc hydrochloride, pH 8.0, 5 mM 
ethylencdiamine tetraacetic acid , 1 X Denhardt's solution, 10% dextran 
sulfatc, 100 mM ditluothreito l, and 2 X 105 cpm of radioactive probe per ILL 
Cell s were mounted on coverslips and hybridized for 12 to 16 h at 
46 -47"C. After hybridization, slides were washed under high-stringency 
conditions (50% formamide, 2 X standard saline citrate, and 5 mM ethyl-
enediamine tetraacetic acid at 54 -57· C). In addition , nonhybridized ptobes 
were removed by RNase treatment [20 ILl RNase A per ILl , 1 unit of RNase 
T l (Boehringer Mannheim, Mannheim, Germany) per ml] for 30 nun at 
room tcmpera turc. Aftcr deh ydration through a graded alcohol series and 
"ir-drying, slides were dipped in Kodak NTB-2 solu tion and exposed for 1 
to 5 wk at 4· C. A Zeiss Axiophot microscopc (Oberkochen, FRG) 
equipped with dark-field illumination was used for eval uation and docu-
men tation of developed slides. Positive cell s were counted in 5-10 high-
power fie lds (X400 magnifica tion) by a " blindcd" obscrver and related to 
thc total number of cells. Data were expressed as mean ± SEM and 
differences were analyzed for statistical significance with Student's t tcst. 
Enzyme-Linked Immunosorbent Assay (ELISA) To study chemo-
kine release by endothelial cells, HDMECs, I-lMEC-l , and HUVECs were 
stimulated for the time inte rva ls indic"ted and supernatan ts we re collected, 
ccntrifuged at 13,000 X g to remove debris , and fro zen un til use for ELISA 
assays . MCP-l production was determined by a sandwich ELISA as 
describcd (sensitivity. 150 pg per ml) (Yoshimura vi nl, 1991; Kuratsu el ai, 
1993). For detection of I~NTES, IL-8, GR.O, MfP-l a, and MIP-l t3, 
sandwich ELISA systcms were purchased from R. & D Systems and 
c1nploycd according to the 111anuf.l c turc r's instructions. T he sensitivities 
werc 2.5 pg per ml for RANTES, 3.0 pg pcr ml for IL-8, 5.0 pg per ml for 
GRO, 2.0 pg per ml for MIP-l a, and 4.0 pg pcr ml for MIP-I {3. For GRO 
ELISA, antibodies "gainst human GR.O -a were employed that exlubited 
< 60% cross-reactivity with GRO-{3 "nd < 30% cross-re"ctivity with 
GRO-I'. N one of thc other assays showcd cross-reactiv ity with related 
chemokines. Data were calculated from dupli ca te we lls and "re presented as 
the mean ± SD. At least three expcrimcnts wcre performed. Differences 
wcre analyzcd fo r statistica l signifi cance with Student's t test. 
RESULTS 
Skin-derived Microvascular Endothelial Cells Produce 
MCP-1 and RANTES upon Cytokine Stimulation HDMECs 
were c ul tured alone or in the presence ofTNF-a, IL-lf3, or IFN--y. 
After 8 h of incubation, expression of C-C c h emokin e mRNA w as 
analyzed by ill sitll h ybrid ization. This m e thod was ch osen because 
it pennits detection of mRNA with hig h specific ity from a rather 
low number of cells like HDMECs, which are available only in a 
limite d number. As shown in Fig 1, TNF- a and IL-1f3 led to a 
strong induction of MCP-l mRNA in HDMECs: both the number 
of mRNA-positive cells and the signal d ensity per cell were 
signifi cantly inc re ased compared to untreated control cells after 
hybridization with a specific M CP-1 anti-sense probe. Not all cells 
exp osed to TNF-a or IL-lf3, however, produced ch emokine 
mRNA. This may be due to the fact that cell cycles were no t 
synchronized under our experimental conditions . For comparabil-
ity , in this and all other figures the data presente d are d erived from 
exp e riments with HDMECs obtained from Clonetics. Sense probe 
were include d in this and all other ill sit ll hybridization experiments 
and consistently revealed n egative results (data not shown) . In the 
absence of stimulatory cytokines, MCP-l m essage could be de-
tected only at low levels. IFN--y and IL-4 did not induce significant 
amounts of MCP-1mRNA in HDMECs (Fig 1 and see also Fig 7). 
Essentially similar results were o btained with the simian virus 
40-immortalized human dermal microvascular e ndothelial cell lin 
HMEC-l (data not shown). W e then performe d ELISA to deter-
mine translation of MCP-l message and secretion into the super-
natant. Mter 24 h of stimulation , both TNF- a and IL-lf3 were 
found to induce secretion of M C P-l ill a concentration-de pendent 
manner (Fig 2A) . The time kinetics of MCP-l accumulation ill 
response to TNF-a showed that secretion of this ch emokine could 
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TNF-a 
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Figure 1. TNF-a and IL-l{:l induce expression of MCP-l and RANTES mRNA in HDMECs. HDMECs wre exposed to medium only (control), 
S ng TNF-a pel' ml , 50 units IL-l ,B per ml, or 1 ng IFN-y per 111.1 for 8 h and processed for ;11 S;111 hybridization w ith anti-sense RNA probes for MC P-l , 
RANTES, o r MIP-l a as described in Mnterinls nlld Methods. Senle bnl', 20 f.Lm. -> indica tcs cells cxpressing chel110kinc mRNA. 
be detected within 8 h, with steadily increasing levels thereafter 
(Fig 2B). 
M ter stimulation with TNF-a or lL-1J3, low levels ofRANTES 
mRNA and protein were induced in HDMECs (Figs 1; 3A) and 
HMEC-l (data not shown), whereas stimulation with IFN-y (Fig 
1) or IL-4 (data not shown) reveal ed no effect . Secretion of low 
levels of RANTES into the supernatant could be observed only 
after 24 h after exposure to TNF-a (Fig 3B), thus showing, 
compared to MCP-l , a slightly retarded kinetic profile . Treatment 
of HDMECs with a combination of T NF-a an d IFN-y revealed a 
synergistic effect resulting in increased production of RANTES 
(Fig 4) that was less impressive in the case of combined treatment 
with IL-l J3 and IFN-y (data not shown) . Coincident treatment of 
HDMECs with IFN-y and T N F-a (or IL-1J3) , however, was not 
found to result in a synergistic increase of MCP-l secretion (Fig 4) . 
In contrast to MCP-l or RANTES, neither MIP-la (Fig 1) nor 
MlP-1J3 (data not shown) were expressed or secreted by HDMECs 
or HMEC-l after stimulation with TNF-a, IL-1J3, IFN-,)" 01' by 
combinations of these agents. Similarly, 1-309 message could not be 
detected in microvascular endothelium after cytokine treatment· 
(data not shown). 
TNF-O' and IL-1/3 Induce Expression of C-X-C Chemokines 
IL-8 and GRO by Dermal Microvascular Endothelinm [1/ 
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35 
15 
30 
e 25 e 
. i 10 
0. 20 ~ .. 
" " 15 :E :E 
= 
g' 
c 
10 
24 h 48 h 
o control ~ TNF·. _ 'L· ll 
- TNF·a 11 ng/ml) 
Ing/m" IU/ml! 
Figure 2. Concentration dependence and kinetics ofMCP-l secretion 
by cytokine-treated HDMECs. (Aj Mtcr 24 h of inc libation widl 0.01-1 0 
ng TNF-a per ml or 1-1000 units 1L-1,B per ml, HDMECs culrure sllpcmatams 
wcre examined for MCP-I concentrations by sand",~ch ELISA as described in 
Mate/inls a/ld lVletlwds. E Il'or bnrs, SD (n = 3). • . Statistically significant 
differcnces as compared to untreated con trol (Scudent's t test, p < 0.05). (Bj 
HDMECs were exposed to 1 ng TNF- a per ml for the times indicated. 
Supematanrs were sllbsequcndy collected and analyzed for MC P-1 production 
as described above. SD of each poine did not exceed 5% of d1e mean value. 
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Figure 3. Concentration dependence and kinetics of RANTES 
secretion by cytokine-treated HDMECs . (A) Cells were exposed to 
T NF-a o r IL- l {3 for 24 h as indica ted, and R ANTES conccn trations in the 
cul ture supernatants were determined by sandwich ELISA as described in 
Malerials {/,,(/ Methods. Em,,' bars, SD (n = 3) . *, Statistically signifi cant 
diffe rcnces as compared to untreated contro l (Studeut's t test, p < 0.05). 
(B) HDMECs were stimulated with 1 ng TNF- a per m l for the periods 
indicated and RANTES secretion into the superna tants was measured by 
sandwich ELISA. SD of each po in t did not exceed 5% of the mean value. 
situ hybridization revea led very few IL-8 mRNA transcripts in 
non stimulated HDMECs (Fig 5) or HMEC-l (data not shown) . 
Upon stimulation with TNF-a or IL-1{3 for 8 h, both the number 
of cells positive for IL-8 mRNA and the signaJ densitiy per ce lJ 
were fo und to be srrongly increased, w hereas IFN-y (Fig 5) or IL-4 
(data not shown) had no sign ificant effect. Essentia lly similar results 
were fo und for GRO chemokines (Fig 5). For detection of GRO 
a GRO-a cDNA probe (Anisowicz et ai, 1987) was employed tba; 
partl y cross-hybridized with GRO-{3 and GRO-y (Haskill et ai, 
1990); thus, aU three related GRO ml~As may be expressed by 
HDMECs. SimiJarly, antibodies against GRO-a employed for 
ELIS A cross-reacted with GRO-f3 and GRO-y (see Materials aHd 
Me/hods) . Secretion of IL-8 and GRO chemokines into the super-
natant as determined by ELISA was maximal at concentrations of 
1-10 ng T N F-a per ml (Fig 6), whereas 1-10 units IL-1f3 per ml 
were sufficient to induce ma"imal IL-8 production. IL-8 and GRO, 
li ke MCP- l (Fig 2B) , were detectable in the supernatant within 8 h 
afte r the initiation of cytokine exposure and accumulated steadily 
thereafter (data not shown) . 
In contrast to IL-8 and GRO, neither ENA-78 (data not shown) 
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Figure 4 . IFN-y and TNF-a act synergistically in the prodnction of 
RANTES but not MCP-t. I-IDMECs were exposed for 24 h to 1 ng 
IFN-y per m l o r 1 ng T NF-a per ml either alolle or in combination . 
Supl!rnat;lI1ts were subsequently collected and studjed for RANTES (A) and 
MCP-1 secretion (B) by sandwich ELlSA. E rror bars, SD (n = 3) . 
" Statistica ll y signifi cant difference as compared to the treatment with 
IFN-y or T NF-a alo ne (Student's t test, p $ 0.05). 
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nor [P-l O mRNA (Fig 5) were detectable after stimulation \vith 
TNF- a or IL-lf3. IFN-y, however, indu ced IP-10 message (Fig 5), 
w hereas ENA-78 was not ex pressed at all. 
IL-4 and IFN-,), Selectively Induce MCP-l Production in 
Macrovascular Endothelium but not in HDMECs and 
HMEC-l Earlier studies reported differences regarding distinct 
functional properties of microvascular and macrovascular endothe-
liUln (Mantovani cI aI, 1992; SwerIick e/ ai, 1992a, 1992b; Petzel-
bauer e/ aI, 1993; GrageI' et aI, 1996) . W e therefore compared 
cytokine regulation of chemokine production in HUVECs with 
those of HDMECs and HMEC- l. A ll three cell types tested 
expressed the sam e pattern of chemokines upon TNF-a and IL-lf3 
stimulation, i.e ., MCP-l , RANTES, IL-8, and GRO, but fa iled to 
produce MIP-la, MlP-lf3, IP-I0 , 1-309, and ENA-78 (data not 
shown) . Regarding the effect ofIL-4, however, differences becam e 
apparent: IL-4 induced significant levels of MCP-l m~A and 
protein in HUVECs. In HDMECs (Figs 7 alld 8) and HMEC-l 
(data not shown) only minute levels of MCP-l w ere expressed. 
T lus was a constant and reproducible finding observed for various 
IL-4 prepa rations obtained from different man ufacturers. Similarly, 
IFN-')' was found to indu ce weak MCP-l expression by HUVECs, 
whereas HDMECs or HMEC-l did not produce significant levels . 
DISCUSSION 
C hemokines are key players in the process ofleukocyte recruitment 
from vasculature in to ti ssues . T he interaction of different chemo-
kines with theil' receptors on leukocytes allows selective activation 
and chemotaxis of neutrophiJs, eosinopluls, lymphocytes, or mono-
cytes necessary for migration to sites of evolving inflammation. 
Regarding their role in cutaneous inflammation, earlier studies have 
focused primarily on keratinocytes, which have been found to 
produce C-X-C chemokines such as IL-8, GRO, and IP-10 and 
C-C chemokines such as MCP-l and RANTES (Barker el aI, 1991; 
BOOl'sma et ai, 1994; Li et aI, 1996). Chemokine production by 
keratinocytes, e.g., IL-8 and M CP- 1, has accordingly been thought 
to account for leukocyte inftltratioll in skin disorders, e .g., into 
psoriatic lesions (Schroder and Christophers, 1986; Gillitzer el al 
1991, 1993) . Other resident cells of the dermal compartment 
producing chemokines include fibroblasts (Sticherling e/ ai, 1993; 
N oso e/ aI, 1996), w hereas the chemokine repertoire of the dermal 
nucrovascular endothelium has not yet been analyzed . T he results 
of our study now demonsrrate that cultured HDMECs are capable 
of producing a unique set of chemokines upon cytokine stimula-
tion, w hich include MCP- 1, RANTES , GRO, IL-8, and IP-I0. In 
addition, . p~eliminary results indicate that MIG (monokine induced 
by IFN- y), a recently described C-X-C chemokine (Farber, 1993), 
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Figure 6. Concentration dependence of TNF-a- and ll.-lt3-in-
duced production of IL-8 and GRO by HDMECs. Cells were incu-
bated w ith 0.01-10 ng TNF-a per ml or 0.1 -1 000 units lL-l{3 per m1 for 
24 h as indicated and supernatants were subsequently analyzed for lL-8 and 
GRO production by sand w ich ELISA. Data arc presented as described in 
Fig 2 . 
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Figure 5 , HDMECs express IL-8 and GRO mRNA upon stimulation with TNF-a or IL-1{3 as well as IP-l0 mRNA upon treatment with 
IFN-,}" Afte r an 8-h exposure to medium alone (control) , 5 ng T NF-a per ml , 50 lIIuts lL-1{3 per ml , or 1 ng IFN-y per ml , HDMECs were processed for 
ill sitll hybridization. Cells were hybridized with IL-8. GRO, or IP-IO anti-sense RNA pro bes as described in Materials a" d M elhods. Data arc presented as 
described in Fig 1 . SCi/ Ie Iwr, 20 /-1-111. -> in dica tes ce lls with chel110kine rnRN A expression. 
HDMEC 
control 
MCP-1 
HUVEC 
Figure 7. Differential induction 
of MCP-1 mRNA by IL-4 in 
HDMECs and HUVECs. Cell s 
were exposed to 1000 lIIurs IL-4 per 
1111 for 8 h and subsequently processed 
for ill sil ll hybtidization with a M C P-
1-specific anti-scnse pro be as de-
scribed in Matelia ls alld M ethods. S cale 
bar, 20 /-1-111. -> indicates cells positive 
fo r MCP- I mRNA expression . 
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Figure 8. Differential induction of MCP-l secretion by IFN-,), and 
IL-4 in HDMECs and HUVECs. Cells were incubated with 0.1-10 ng 
IFN-y per Illl or 10-1000 units IL-4 per Illl for a period of24 h as indicated. 
Subsequently, MCP-I concentrations in the culture supernatants were 
determined by sandwich ELISA. Enol' bars. SD (n = 3) . *, Statistically 
significant differences as compared to untreated control (Student's t test, 
p < 0.05). 
is inducible in HDMECs upon exposure to IFN-')', but not upon 
stimulation with IL-1, TNF-a, or IL-4 (R. Gillitzer and M . 
Goebeler, unpubUshed observations). Whether the C-C chemo-
kine eotaxlll, a recently cloned human eosinophil chemoattractant 
(Ponath et ai, 1996), which has been shown to be produced by 
HUVECs upon stimulation with TNF-a, IL-1, or IFN-')' (Garcia-
Zepeda et aI, 1996), is al so synthesized by HDMECs is currently 
under investigation. Other m embers of the C-C and C-X-C 
chemokine famiUes such as 1-309, ENA-78, MIP-1a, and MIP-1{3 
were not found to be expressed by microvascular endothelium 
upon cytokine treatment. 
Structural and functional differences between endothelial cells 
obtained from micro- and m acrovascular sites have been reported 
in recent years. HDMECs have been demonstrated to express the 
thrombosp.ondin receptor CD36 (Swerlick et aI, 1992a) and the 
Fc')'RII (CD32) (Groger el aI, 1996); neither can be found on 
HUVECs. Furthermore, differences in cytokine regulation of ad-
hesion molecules and integrins have been observed (SwerUck e/ ai, 
1992b ; Petzelbauer el ai, 1993; Sepp et ai, 1994) . It was therefore 
important to compare the chemokine pattern of HUVECs (Luster 
and R avetch, 1987; Malltovani e/ ai, 1992; Marfaing Koka et ai, 
1995) with that of HDMECs. Chemokines MCP-1, RANTES, 
GRO, and IL-8 h a.ve earUer been found to be produced by 
HUVECs (Gimbrone et ai, 1989; ScHroder and Christophers, 1989; 
Wen e/ ai, 1989; Rollins et aI, 1990; Marfaing Koka et aI, 1995); our 
data now provide evidence that regulation by TNF-a and IL-l (3 is 
rather similar in both HDMECs and HUVECs. Both endotheUal 
cell types fa.iled to produce MIP-1a, MIP-1{3, 1-309 , and ENA- 78. 
Differences becam e apparent, however, regarding regulation by 
IFN-')' and IL-4 : exposure to IFN-')' or IL-4 resulted in expression 
of MCP-1 by HUVECs (Rollins e/ ai, 1990; Rollins and Pober, 
1991) but not by HDMECs. Inability of IFN-')' to significantly 
upregulate MCP-1 in HDMECs did not appear to reflect complete 
unresponsiveness to thjs cytokine, because TNF-a- induced micro-
vascul ar RANTES expression is synergistically increased by con-
comitant treatment with IFN-y. In addition , HDMECs, Uke 
HUVECs, express IP-10 upon stimulation with IFN-')'. In contrast 
to our observations, human lung microvascular endothelial cells 
have been show n to produce MCP-1 after IFN-')' stimulation 
(Brown et ai, 1994) ; these divergent results m ay reflect site-specific 
differences. R egarding MCP-1 regulation by IL-4, similar results 
were reported for vascular cell adhesion molecule-l. Vascular cell 
adhesion molecule-1 is induced by IL-4 in HUVECs but not in 
HDMECs (Swerlick e/ aI, 1992b; Petzelbauer el aI, 1993) . Unre-
sponsiveness to IL-4 is not due to the absence of IL-4 receptor a 
and common ')'C chains, the components of the IL-4 receptor 
-, 
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(Callard e/ aI, 1996), because HDMECs, like HUVECs, express 
both (Goebeler e/ ai, unpublished observation). Wheth er potential 
differences in Janus kinase/signal transducers and activators of 
transcription signaling pathways may account for differential regu-
lation is currently being inves tigated. 
We also analyzed whether HMEC-1, a dermal microvascular 
endothelial cell line immortalized by simian virus 40 transformation 
(Ades et ai, 1992), may serve as a substitu te for primary HDMECs 
with regard to its chemokine repertoire. HMEC-1, with the 
exception of E- selectin expression, closely resembles HDMECs 
w ith respect to adhesion molecules and other properties but mimics 
HUVECs in lacking CD36 and n eural cell adhesion molecule 
expression (Xu cf ai, 1994). Our study demonstrates that the 
chemokine profile of HMEC-1 and its regulation by cytokines, 
including fail ure of MCP-1 induction by IFN-')' and IL-4 , is 
equivalent to that observed for HDMECs. 
Secretion of endogenously produced chemokines by endothelial 
cells is increasingly being appreciated to promote transendothelial 
migration of leukocytes. An ;11 11;11'0 study recently revealed that 
endotheUal cells secre te MCP-1 at both their luminal and ab lU111inal 
sides (Randolph and FUlie, 1995) . Because apically released 
MCP-l, due to blood flow conditions, is more rapidly diluted than 
the MCP-l fraction secreted into the subendothelial matrix , a 
soluble gradient of chemokine may be es tablished that promotes 
transen dothelial migration of leukocytes. C hemokines such as 
MCP-1 , furthermore, m odulate avidity of leukocyte integrins, 
which appears to be important for transendothe Li al migration and 
for migration thro ugh the subendotheUal extracellular matrix 
(Springer, 1994; Carr et aI, 1996; Lloyd et ai, 1996). In addition to 
promotion by a gradient of soluble chemoattractants, leukocyte 
transmigration through th e vascular wall may be induced by 
endogenously produced chemokine that may, as described for IL-8, 
be immobilized on the luminal endothelial cell surface (Rot et ai, 
1996) or deposited in the subendothelial extracellular matrL" 
(Huber et aI, 1991). 
Our observation that dermal microvascular endothelium pro-
duces a distinct pattem of chemokil1es upon appropriate cytokine 
stimulation provides evidence for their potential to contribute to 
site-specific and selective recruitment of neutrophils, eosinophils, 
monocytes, and lymphocytes into the skin. Future studies analyzing 
the ;1'1 S;lH expression of chemokines by the dermal microvasculature 
may help to better understand m echanisms ofleukocyte infiltration 
in cutaneous di sorders. 
Wc thallk Drs. E. W. A llcs (Ccll lers for Diseasc COlltro/, A t/allla, GA) alld T J. 
Law/ey (EllIO IY Ulli llersily, A t/allla, GA) for killd/y prollidillg tlte immortalized 
Itllmall IIIicrollasCII/al' cllllotilclia/ ccll lil/ c HMEC-1 . 
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